Compare $TPST vs $ZEOX | Chartloom

Compare

$TPST vs $ZEOX

Tempest Therapeutics Inc · ZEO ScientifiX Inc

TPST

Tempest Therapeutics Inc

ZEOX

ZEO ScientifiX Inc

Compare $TPST vs $ZEOX

Comparing Tempest Therapeutics Inc and ZEO ScientifiX Inc

TPSTTempest Therapeutics Inc

ZEOXZEO ScientifiX Inc

TPSTTempest Therapeutics Inc

Market cap

$12M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-6.3%

YTD performance

-74.2%

52W performance

-93.1%

FCF yield

-170.7%

ZEOXZEO ScientifiX Inc

Market cap

$9M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

52.8%

YTD performance

-55.7%

52W performance

-16.5%

FCF yield

-14.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

TPST

ZEOX

Detailed metrics comparison

TPST

Tempest Therapeutics Inc

ZEOX

ZEO ScientifiX Inc

Market Cap

TPST$12M

ZEOX$9M

Enterprise Value

TPST$11M

ZEOX$8M

Price

TPST$0.76

ZEOX$1.19

P/E Ratio

TPSTN/A

ZEOXN/A

P/S Ratio

TPST45.67x

ZEOX1.33x

EV/Sales

TPST43.07x

ZEOX1.11x

EV/EBITDA

TPST0.00x

ZEOX0.00x

P/B Ratio

TPST16.67x

ZEOX16.07x

P/FCF Ratio

TPSTN/A

ZEOXN/A

EV/FCF

TPST-0.55x

ZEOX-5.77x

PEG Ratio

TPSTN/A

ZEOXN/A

Forward P/E (NTM)

TPSTN/A

ZEOXN/A

Forward P/S (NTM)

TPSTN/A

ZEOXN/A

Revenue (TTM)

TPST$0

ZEOX$7M

Revenue Growth (YoY)

TPST-6.3%

ZEOX52.8%

Forward Rev Growth

TPST0.0%

ZEOX0.0%

Gross Margin (TTM)

TPST0.0%

ZEOX81.5%

Operating Margin (TTM)

TPST0.0%

ZEOX0.0%

EBITDA Margin (TTM)

TPST0.0%

ZEOX-58.0%

Net Margin (TTM)

TPST0.0%

ZEOX-55.6%

FCF Margin (TTM)

TPSTN/A

ZEOX-19.3%

Net Income (TTM)

TPST$-40M

ZEOX$-4M

FCF (TTM)

TPST$-21M

ZEOX$-1M

EPS (TTM)

TPST-$2.66

ZEOX-$0.50

ROE (TTM)

TPST-72989.0%

ZEOX0.0%

ROA (TTM)

TPST-29736.0%

ZEOX-16123.0%

ROIC (TTM)

TPST-72989.0%

ZEOX0.0%

Cash

TPST$779K

ZEOX$2M

Debt

TPST$0

ZEOX$343K

Net Cash/Debt

TPST$779K

ZEOX$2M

Current Ratio (TTM)

TPST0.38x

ZEOX1.05x

Quick Ratio (TTM)

TPST0.27x

ZEOX0.68x

Debt/Equity (TTM)

TPST0.00x

ZEOX0.48x

Debt/Assets (TTM)

TPST0.0%

ZEOX0.0%

Interest Coverage (TTM)

TPSTN/A

ZEOXN/A

Net Debt/EBITDA (TTM)

TPST0.00x

ZEOX0.00x

Beta

TPST-1.61

ZEOX1.94

52W Performance

TPST-93.1%

ZEOX-16.5%

YTD Performance

TPST-74.2%

ZEOX-55.7%

% from 52W High

TPST-93.8%

ZEOX-60.4%

% from 52W Low

TPST2.3%

ZEOX22.2%

Asset Turnover (TTM)

TPST0.01x

ZEOX2.90x

FCF Yield (TTM)

TPST-170.7%

ZEOX-14.5%

Earnings Yield (TTM)

TPST-333.2%

ZEOX-41.8%

Dividend Yield (TTM)

TPSTN/A

ZEOXN/A

Rule of 40

TPST-6.3

ZEOX33.4

EV/GP/RG

TPSTN/A

ZEOXN/A

Ticker research

View TPST research View ZEOX research

Metric	TPST Tempest Therapeutics Inc	ZEOX ZEO ScientifiX Inc
Market & Valuation
Market Cap	$12M	$9M
Enterprise Value	$11M	$8M
Price	$0.76	$1.19
P/E Ratio	N/A	N/A
P/S Ratio	45.67x	1.33x
EV/Sales	43.07x	1.11x
EV/EBITDA	0.00x	0.00x
P/B Ratio	16.67x	16.07x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.55x	-5.77x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$7M
Revenue Growth (YoY)	-6.3%	52.8%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	81.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-58.0%
Net Margin (TTM)	0.0%	-55.6%
FCF Margin (TTM)	N/A	-19.3%
Net Income (TTM)	$-40M	$-4M
FCF (TTM)	$-21M	$-1M
EPS (TTM)	-$2.66	-$0.50
ROE (TTM)	-72989.0%	0.0%
ROA (TTM)	-29736.0%	-16123.0%
ROIC (TTM)	-72989.0%	0.0%
Financial Health
Cash	$779K	$2M
Debt	$0	$343K
Net Cash/Debt	$779K	$2M
Current Ratio (TTM)	0.38x	1.05x
Quick Ratio (TTM)	0.27x	0.68x
Debt/Equity (TTM)	0.00x	0.48x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-1.61	1.94
52W Performance	-93.1%	-16.5%
YTD Performance	-74.2%	-55.7%
% from 52W High	-93.8%	-60.4%
% from 52W Low	2.3%	22.2%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	2.90x
FCF Yield (TTM)	-170.7%	-14.5%
Earnings Yield (TTM)	-333.2%	-41.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-6.3	33.4
EV/GP/RG	N/A	N/A
Ticker research	View TPST research	View ZEOX research

Valuation

P/S Ratio

ZEOX

1.33x

TPST

45.67x

EV/FCF

ZEOX

-5.77x

TPST

-0.55x

Growth & revenue

Revenue Growth TTM

ZEOX

52.8%

TPST

-6.3%

Forward Revenue Growth

TPST

0.0%

ZEOX

0.0%

Profitability & performance

Gross Margin

ZEOX

81.5%

TPST

0.0%

ROE

ZEOX

0.0%

TPST

-72989.0%

FCF Yield %

ZEOX

-14.5%

TPST

-170.7%

52-Week Performance

ZEOX

-16.5%

TPST

-93.1%

Detailed metrics comparison

TPST

Tempest Therapeutics Inc

ZEOX

ZEO ScientifiX Inc

Market Cap

TPST$12M

ZEOX$9M

Enterprise Value

TPST$11M

ZEOX$8M

Price

TPST$0.76

ZEOX$1.19

P/E Ratio

TPSTN/A

ZEOXN/A

P/S Ratio

TPST45.67x

ZEOX1.33x

EV/Sales

TPST43.07x

ZEOX1.11x

EV/EBITDA

TPST0.00x

ZEOX0.00x

P/B Ratio

TPST16.67x

ZEOX16.07x

P/FCF Ratio

TPSTN/A

ZEOXN/A

EV/FCF

TPST-0.55x

ZEOX-5.77x

PEG Ratio

TPSTN/A

ZEOXN/A

Forward P/E (NTM)

TPSTN/A

ZEOXN/A

Forward P/S (NTM)

TPSTN/A

ZEOXN/A

Revenue (TTM)

TPST$0

ZEOX$7M

Revenue Growth (YoY)

TPST-6.3%

ZEOX52.8%

Forward Rev Growth

TPST0.0%

ZEOX0.0%

Gross Margin (TTM)

TPST0.0%

ZEOX81.5%

Operating Margin (TTM)

TPST0.0%

ZEOX0.0%

EBITDA Margin (TTM)

TPST0.0%

ZEOX-58.0%

Net Margin (TTM)

TPST0.0%

ZEOX-55.6%

FCF Margin (TTM)

TPSTN/A

ZEOX-19.3%

Net Income (TTM)

TPST$-40M

ZEOX$-4M

FCF (TTM)

TPST$-21M

ZEOX$-1M

EPS (TTM)

TPST-$2.66

ZEOX-$0.50

ROE (TTM)

TPST-72989.0%

ZEOX0.0%

ROA (TTM)

TPST-29736.0%

ZEOX-16123.0%

ROIC (TTM)

TPST-72989.0%

ZEOX0.0%

Cash

TPST$779K

ZEOX$2M

Debt

TPST$0

ZEOX$343K

Net Cash/Debt

TPST$779K

ZEOX$2M

Current Ratio (TTM)

TPST0.38x

ZEOX1.05x

Quick Ratio (TTM)

TPST0.27x

ZEOX0.68x

Debt/Equity (TTM)

TPST0.00x

ZEOX0.48x

Debt/Assets (TTM)

TPST0.0%

ZEOX0.0%

Interest Coverage (TTM)

TPSTN/A

ZEOXN/A

Net Debt/EBITDA (TTM)

TPST0.00x

ZEOX0.00x

Beta

TPST-1.61

ZEOX1.94

52W Performance

TPST-93.1%

ZEOX-16.5%

YTD Performance

TPST-74.2%

ZEOX-55.7%

% from 52W High

TPST-93.8%

ZEOX-60.4%

% from 52W Low

TPST2.3%

ZEOX22.2%

Asset Turnover (TTM)

TPST0.01x

ZEOX2.90x

FCF Yield (TTM)

TPST-170.7%

ZEOX-14.5%

Earnings Yield (TTM)

TPST-333.2%

ZEOX-41.8%

Dividend Yield (TTM)

TPSTN/A

ZEOXN/A

Rule of 40

TPST-6.3

ZEOX33.4

EV/GP/RG

TPSTN/A

ZEOXN/A

Ticker research

View TPST research View ZEOX research

Metric	TPST Tempest Therapeutics Inc	ZEOX ZEO ScientifiX Inc
Market & Valuation
Market Cap	$12M	$9M
Enterprise Value	$11M	$8M
Price	$0.76	$1.19
P/E Ratio	N/A	N/A
P/S Ratio	45.67x	1.33x
EV/Sales	43.07x	1.11x
EV/EBITDA	0.00x	0.00x
P/B Ratio	16.67x	16.07x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.55x	-5.77x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$7M
Revenue Growth (YoY)	-6.3%	52.8%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	81.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-58.0%
Net Margin (TTM)	0.0%	-55.6%
FCF Margin (TTM)	N/A	-19.3%
Net Income (TTM)	$-40M	$-4M
FCF (TTM)	$-21M	$-1M
EPS (TTM)	-$2.66	-$0.50
ROE (TTM)	-72989.0%	0.0%
ROA (TTM)	-29736.0%	-16123.0%
ROIC (TTM)	-72989.0%	0.0%
Financial Health
Cash	$779K	$2M
Debt	$0	$343K
Net Cash/Debt	$779K	$2M
Current Ratio (TTM)	0.38x	1.05x
Quick Ratio (TTM)	0.27x	0.68x
Debt/Equity (TTM)	0.00x	0.48x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-1.61	1.94
52W Performance	-93.1%	-16.5%
YTD Performance	-74.2%	-55.7%
% from 52W High	-93.8%	-60.4%
% from 52W Low	2.3%	22.2%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	2.90x
FCF Yield (TTM)	-170.7%	-14.5%
Earnings Yield (TTM)	-333.2%	-41.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-6.3	33.4
EV/GP/RG	N/A	N/A
Ticker research	View TPST research	View ZEOX research